Seidman E G, Hanson D G, Walker W A
Gastroenterology. 1986 Jan;90(1):120-6. doi: 10.1016/0016-5085(86)90083-1.
Little information is available regarding colonic permeability to macromolecules in health or disease states. In vivo permeability of rabbit colon to [14C]polyethylene glycol 4000 (14C-PEG) was examined in the presence of immune complex-mediated experimental colitis and compared with that of partially treated (control) and normal rabbits. Permeability was assessed by urinary 14C-PEG excretion after intrarectal administration of 0.1 mM solution of 14C-PEG (1 ml/kg, 7.5 X 10(6) cpm/ml). Experimental colitis greatly increased colonic permeability (p less than 0.001 in two-way analysis of variance) compared with control and normal groups (2.06% +/- 0.19%, 0.14% +/- 0.04%, and 0.01% +/- 0.004%, respectively, of rectally administered counts). Gel diffusion chromatography showed that absorbed 14C-PEG was excreted into urine unchanged, demonstrating its applicability as an inert, nonmetabolizable macromolecular probe. Urinary clearance after mesenteric vein administration of 14C-PEG was similar in normal animals and animals with colitis, implicating colonic absorption as the source of the group differences. Postmortem histology confirmed the acute colitis lesions in the experimental group. These findings support the hypothesis that nonspecific colonic inflammation is associated with significant alterations of mucosal permeability.
关于健康或疾病状态下结肠对大分子的通透性,目前可用信息较少。在免疫复合物介导的实验性结肠炎存在的情况下,检测了兔结肠对[14C]聚乙二醇4000(14C-PEG)的体内通透性,并与部分治疗(对照)兔和正常兔进行了比较。通过直肠内给予0.1 mM的14C-PEG溶液(1 ml/kg,7.5×10(6) cpm/ml)后尿中14C-PEG的排泄来评估通透性。与对照组和正常组相比,实验性结肠炎大大增加了结肠通透性(双向方差分析中p<0.001)(直肠给药计数的百分比分别为2.06%±0.19%、0.14%±0.04%和0.01%±0.004%)。凝胶扩散色谱显示,吸收的14C-PEG原样排泄到尿液中,表明其作为一种惰性、不可代谢的大分子探针的适用性。正常动物和患有结肠炎的动物在肠系膜静脉注射14C-PEG后的尿清除率相似,这表明结肠吸收是组间差异的来源。死后组织学证实了实验组的急性结肠炎病变。这些发现支持了非特异性结肠炎症与粘膜通透性显著改变相关的假说。